Fairmount Partners Advises ICON plc in Acquisition of Mapi Group

DUBLIN, IRELAND – July 17, 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, announced that it has acquired the Mapi Group, a leading Patient-Centered Health Outcomes Research and Commercialisation company. The acquisition strengthens ICON’s existing Commercialisation and Outcomes Research business […]